
NATURE . COM {
}
Title:
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab | British Journal of Cancer
Description:
Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20 mg kg−1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5–0.9 ng ml−1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, ρ=−0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (ρ=0.594, P=0.021) and inversely with E-cadherin (ρ=–0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.
Keywords {🔍}
patients, igf, figf, levels, cancer, article, growth, pcf, igfbp, google, scholar, insulin, nsclc, benefit, factor, cas, clinical, pfs, insulinlike, ratio, therapy, baseline, pretreatment, tumour, clin, nature, free, predictive, study, figure, gualberto, months, pollak, receptor, lung, bioactivity, data, igfir, binding, high, usa, circulating, treatment, criteria, analysis, identify, figitumumab, ecadherin, total, receiving,
Topics {✒️}
nature portfolio privacy policy research nature middle line represents advertising thermo scientific body mass index social media author information authors 0/ reprints italy assessing her2/neu amplification assessing k-ras mutations drug development full size image author correspondence eml4-alk gene fusion eml4-alk fusion gene open-label open label rabbit anti-pan-cytokeratin small-cell lung cancer pre-treatment circulating levels receiver-operating characteristic total alanine-scanning mutagenesis growth factor-binding proteins kaplan–meier curves plasma concentration–time curve low e-cadherin expression anti-igf-ir therapy high pre-treatment levels f-ihc aqua scores pre-treatment biomarker tests pre-treatment figf-1 levels binding protein-3-selective insulin chemotherapy-naïve stage iiib mouse anti-e-cadherin long-term clinical benefit tumour e-cadherin/vimentin ratio patients received pc significant biomarker/treatment interaction pre-treatment figf-1 criteria permissions small sample size egf receptor family progression-free survival clinical development dolled-filhart mp higher baseline levels
Schema {🗺️}
WebPage:
mainEntity:
headline:Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
description:Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20âmgâkgâ1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5â0.9ângâmlâ1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, Ï=â0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (Ï=0.594, P=0.021) and inversely with E-cadherin (Ï=â0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
datePublished:2010-11-23T00:00:00Z
dateModified:2012-03-29T00:00:00Z
pageStart:68
pageEnd:74
sameAs:https://doi.org/10.1038/sj.bjc.6605972
keywords:
Drug therapy
Non-small-cell lung cancer
Predictive markers
IGF-IR
IGF-1
figitumumab
NSCLC
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig5_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
type:Person
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
type:Person
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
description:Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20âmgâkgâ1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5â0.9ângâmlâ1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, Ï=â0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (Ï=0.594, P=0.021) and inversely with E-cadherin (Ï=â0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
datePublished:2010-11-23T00:00:00Z
dateModified:2012-03-29T00:00:00Z
pageStart:68
pageEnd:74
sameAs:https://doi.org/10.1038/sj.bjc.6605972
keywords:
Drug therapy
Non-small-cell lung cancer
Predictive markers
IGF-IR
IGF-1
figitumumab
NSCLC
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig5_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
type:Person
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
type:Person
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
PostalAddress:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:HistoRx Inc., New Haven, USA
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
name:Department of Medical Oncology, West Clinic, Memphis, USA
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
name:Department of Medical Oncology, McGill University, Montreal, Canada
External Links {🔗}(103)
- How much revenue does https://doi.org/10.1038/bjc.2012.497 generate?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10404797?
- See how much http://scholar.google.com/scholar_lookup?&title=Changes%20in%20free%20insulin-like%20growth%20factor-1%20and%20leptin%20concentrations%20during%20acute%20metabolic%20decompensation%20in%20insulin%20withdrawn%20patients%20with%20type%201%20diabetes&journal=J%20Clin%20Endocrinol%20Metab&volume=84&pages=2324-2328&publication_year=1999&author=Attia%2CN&author=Caprio%2CS&author=Jones%2CTW&author=Heptulla%2CR&author=Holcombe%2CJ&author=Silver%2CD&author=Sherwin%2CRS&author=Tamborlane%2CWV makes per month
- Find out how much https://doi.org/10.1046%2Fj.1365-2265.1996.7760786.x earns monthly
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Insulin%20treatment%20normalizes%20reduced%20free%20insulin-like%20growth%20factor-I%20concentrations%20in%20diabetic%20children&journal=Clin%20Endocrinol%20%28Oxf%29&doi=10.1046%2Fj.1365-2265.1996.7760786.x&volume=45&pages=321-326&publication_year=1996&author=Bereket%2CA&author=Lang%2CCH&author=Blethen%2CSL&author=Ng%2CLC&author=Wilson%2CTA?
- What's the financial gain of https://doi.org/10.1258%2F000456307780945778?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20biochemical%20assessment%20of%20insulin%20resistance&journal=Ann%20Clin%20Biochem&doi=10.1258%2F000456307780945778&volume=44&pages=324-342&publication_year=2007&author=Borai%2CA&author=Livingstone%2CC&author=Ferns%2CGA?
- How much revenue does https://doi.org/10.1210%2Fjc.2007-2454 bring in?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Normal%20values%20of%20circulating%20insulin-like%20growth%20factor-I%20bioactivity%20in%20the%20healthy%20population%3A%20comparison%20with%20five%20widely%20used%20IGF-1%20immunoassays&journal=J%20Clin%20Endocrinol%20Metab&doi=10.1210%2Fjc.2007-2454&volume=93&pages=2539-2545&publication_year=2008&author=Brugts%2CMP&author=Ranke%2CMB&author=Hofland%2CLJ&author=van%20der%20Wansem%2CK&author=Weber%2CK&author=Frystyk%2CJ&author=Lamberts%2CSW&author=Janssen%2CJA making per month?
- How much income is https://doi.org/10.1210%2Fjc.2007-1633 earning monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Low%20circulating%20insulin-like%20growth%20factor%20I%20bioactivity%20in%20elderly%20men%20is%20associated%20with%20increased%20mortality&journal=J%20Clin%20Endocrinol%20Metab&doi=10.1210%2Fjc.2007-1633&volume=93&pages=2515-2522&publication_year=2008&author=Brugts%2CMP&author=van%20den%20Beld%2CAW&author=Hofland%2CLJ&author=van%20der%20Wansem%2CK&author=van%20Koetsveld%2CPM&author=Frystyk%2CJ&author=Lamberts%2CSW&author=Janssen%2CJA?
- Check the income stats for https://doi.org/10.2337%2Fdb09-0583
- How much profit does http://scholar.google.com/scholar_lookup?&title=Igf-I%20bioactivity%20in%20an%20elderly%20population%3A%20relation%20to%20insulin%20sensitivity%2C%20insulin%20levels%2C%20and%20the%20metabolic%20syndrome&journal=Diabetes&doi=10.2337%2Fdb09-0583&volume=59&pages=505-508&publication_year=2010&author=Brugts%2CMP&author=van%20Duijn%2CCM&author=Hofland%2CLJ&author=Witteman%2CJC&author=Lamberts%2CSW&author=Janssen%2CJA generate?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12473592?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Clinical%20significance%20of%20insulin-like%20growth%20factor-binding%20protein-3%20expression%20in%20stage%20I%20non-small%20cell%20lung%20cancer&journal=Clin%20Cancer%20Res&volume=8&pages=3796-3802&publication_year=2002&author=Chang%2CYS&author=Kong%2CG&author=Sun%2CS&author=Liu%2CD&author=El-Naggar%2CAK&author=Khuri%2CFR&author=Hong%2CWK&author=Lee%2CHY
- How much profit does https://doi.org/10.1158%2F1078-0432.CCR-07-4879 generate?
- How much profit is http://scholar.google.com/scholar_lookup?&title=The%20type%201%20insulin-like%20growth%20factor%20receptor%20pathway&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4879&volume=14&pages=6364-6370&publication_year=2008&author=Chitnis%2CMM&author=Yuen%2CJS&author=Protheroe%2CAS&author=Pollak%2CM&author=Macaulay%2CVM making per month?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-04-1070 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Combination%20therapy%20enhances%20the%20inhibition%20of%20tumor%20growth%20with%20the%20fully%20human%20anti-type%201%20insulin-like%20growth%20factor%20receptor%20monoclonal%20antibody%20CP-751%2C871&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-1070&volume=11&pages=2063-2073&publication_year=2005&author=Cohen%2CBD&author=Baker%2CDA&author=Soderstrom%2CC&author=Tkalcevic%2CG&author=Rossi%2CAM&author=Miller%2CPE&author=Tengowski%2CMW&author=Wang%2CF&author=Gualberto%2CA&author=Beebe%2CJS&author=Moyer%2CJD pull in?
- How much income does https://doi.org/10.1021%2Fbi990089p have?
- How much money does http://scholar.google.com/scholar_lookup?&title=Total%20alanine-scanning%20mutagenesis%20of%20insulin-like%20growth%20factor%20I%20%28IGF-1%29%20identifies%20differential%20binding%20epitopes%20for%20IGFBP-1%20and%20IGFBP-3&journal=Biochemistry&doi=10.1021%2Fbi990089p&volume=38&pages=6386-6396&publication_year=1999&author=Dubaqui%C3%A9%2CY&author=Lowman%2CHB generate?
- What's the income generated by https://doi.org/10.1210%2Fendo.142.1.7864 each month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Binding%20protein-3-selective%20insulin-like%20growth%20factor%20I%20variants%3A%20engineering%2C%20biodistributions%2C%20and%20clearance&journal=Endocrinology&doi=10.1210%2Fendo.142.1.7864&volume=142&pages=165-173&publication_year=2001&author=Dubaqui%C3%A9%2CY&author=Mortensen%2CDL&author=Intintoli%2CA&author=Hogue%2CDA&author=Nakamura%2CG&author=Rancatore%2CP&author=Lester%2CP&author=Sadick%2CMD&author=Filvaroff%2CE&author=Fielder%2CPJ&author=Lowman%2CHB?
- What's the income generated by https://doi.org/10.1002%2Fijc.2910560618 each month?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Expression%20and%20function%20of%20the%20insulin%20like%20growth%20factor%201%20system%20in%20human%20non%20small%20cell%20lung%20cancer%20and%20normal%20lung%20cell%20lines&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.2910560618&volume=56&pages=858-866&publication_year=1994&author=Favoni%2CRE&author=de%20Cupis%2CA&author=Ravera%2CF&author=Cantoni%2CC&author=Pirani%2CP&author=Ardizzoni%2CA&author=Noonan%2CD&author=Biassoni%2CR?
- How much revenue does https://link.springer.com/doi/10.1007/s11102-007-0025-y produce monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Utility%20of%20free%20IGF-1%20measurements&journal=Pituitary&doi=10.1007%2Fs11102-007-0025-y&volume=10&pages=181-187&publication_year=2007&author=Frystyk%2CJ
- What's the profit of https://doi.org/10.1517%2F14712591003689980?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Figitumumab%20%28CP-751%2C871%29%20for%20cancer%20therapy&journal=Expert%20Opin%20Biol%20Ther&doi=10.1517%2F14712591003689980&volume=10&pages=575-585&publication_year=2010&author=Gualberto%2CA?
- How much does https://doi.org/10.1200%2FJCO.2008.21.7695 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Molecular%20basis%20for%20sensitivity%20to%20figitumumab%20%28CP-751%2C871%29%20in%20NSCLC&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.21.7695&volume=27&publication_year=2009&author=Gualberto%2CA&author=Dolled-Filhart%2CMP&author=Hixon%2CML&author=Christensen%2CJ&author=Rimm%2CDL&author=Lee%2CAV&author=Wang%2CY&author=Pollak%2CM&author=Paz-Ares%2CLG&author=Karp%2CDD make?
- What are the total earnings of https://doi.org/10.1038%2Fonc.2009.172?
- Profit of http://scholar.google.com/scholar_lookup?&title=Emerging%20role%20of%20insulin-like%20growth%20factor%20receptor%20inhibitors%20in%20oncology%3A%20early%20clinical%20trial%20results%20and%20future%20directions&journal=Oncogene&doi=10.1038%2Fonc.2009.172&volume=28&pages=3009-3021&publication_year=2009&author=Gualberto%2CA&author=Pollak%2CM
- https://doi.org/10.1016%2Fj.lungcan.2006.07.014 income
- How much does http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20pretreatment%20plasma%20levels%20of%20insulin-like%20growth%20factor%20%28IGF%29-1%2C%20IGF-2%2C%20and%20IGF%20binding%20protein-3%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2006.07.014&volume=54&pages=227-234&publication_year=2006&author=Han%2CJY&author=Choi%2CBG&author=Choi%2CJY&author=Lee%2CSY&author=Ju%2CSY pull in?
- Earnings of https://doi.org/10.1161%2F01.ATV.18.2.277
- How much does http://scholar.google.com/scholar_lookup?&title=Serum%20total%20IGF-1%2C%20free%20IGF-1%2C%20and%20IGFB-1%20levels%20in%20an%20elderly%20population%3A%20relation%20to%20cardiovascular%20risk%20factors%20and%20disease&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2F01.ATV.18.2.277&volume=18&pages=277-282&publication_year=1998&author=Janssen%2CJA&author=Stolk%2CRP&author=Pols%2CHA&author=Grobbee%2CDE&author=Lamberts%2CSW earn?
- How much does https://doi.org/10.1200%2Fjco.2010.28.15_suppl.7500 gross monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20open%20label%2C%20phase%20III%20trial%20of%20figitumumab%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20versus%20paclitaxel%20and%20carboplatin%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20%28NSCLC%29&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2010.28.15_suppl.7500&volume=28&publication_year=2010&author=Jassem%2CJ&author=Langer%2CCJ&author=Karp%2CDD&author=Mok%2CT&author=Benner%2CRJ&author=Green%2CSJ&author=Park%2CK&author=Novello%2CS&author=Strausz%2CJ&author=Gualberto%2CA?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20insulin-like%20growth%20factors%20in%20the%20epithelial%20to%20mesenchymal%20transition&publication_year=2005&author=Julien-Grille%2CS&author=Moore%2CR&author=Denat%2CL&author=Morali%2COG&author=Delmas%2CV&author=Bellacosa%2CA&author=Laure%2CL produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9253324 rake in every month?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Free%20insulin-like%20growth%20factor%20I%20serum%20levels%20in%201430%20healthy%20children%20and%20adults%2C%20and%20its%20diagnostic%20value%20in%20patients%20suspected%20of%20growth%20hormone%20deficiency&journal=J%20Clin%20Endocrinol%20Metab&volume=82&pages=2497-2502&publication_year=1997&author=Juul%2CA&author=Holm%2CK&author=Kastrup%2CKW&author=Pedersen%2CSA&author=Michaelsen%2CKF&author=Scheike%2CT&author=Rasmussen%2CS&author=M%C3%BCller%2CJ&author=Skakkebaek%2CNE?
- How much does https://doi.org/10.1172%2FJCI39104 pull in?
- What's the income of http://scholar.google.com/scholar_lookup?&title=The%20basics%20of%20epithelial%E2%80%93mesenchymal%20transition&journal=J%20Clin%20Invest&doi=10.1172%2FJCI39104&volume=119&pages=1420-1428&publication_year=2009&author=Kalluri%2CR&author=Weinberg%2CRA?
- Explore the financials of https://doi.org/10.1200%2FJCO.2008.19.9331
- Earnings of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20the%20anti-insulin-like%20growth%20factor%20type%201%20receptor%20antibody%20CP-751%2C871%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20in%20previously%20untreated%2C%20locally%20advanced%2C%20or%20metastatic%20non-small-cell%20lung%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.19.9331&volume=27&pages=2516-2522&publication_year=2009&author=Karp%2CDD&author=Paz-Ares%2CLG&author=Novello%2CS&author=Haluska%2CP&author=Garland%2CL&author=Cardenal%2CF&author=Blakely%2CLJ&author=Eisenberg%2CPD&author=Langer%2CCJ&author=Blumenschein%2CG&author=Johnson%2CFM&author=Green%2CS&author=Gualberto%2CA
- What's the financial intake of https://doi.org/10.1016%2F1357-2725%2896%2900005-2?
- How much does http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-binding%20proteins%20%28IGFBPs%29%20and%20their%20regulatory%20dynamics&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2F1357-2725%2896%2900005-2&volume=28&pages=619-637&publication_year=1996&author=Kelley%2CKM&author=Oh%2CY&author=Gargosky%2CSE&author=Gucev%2CZ&author=Matsumoto%2CT&author=Hwa%2CV&author=Ng%2CL&author=Simpson%2CDM&author=Rosenfeld%2CRG generate monthly?
- Find out how much https://doi.org/10.1158%2F1078-0432.CCR-08-0168 earns monthly
- How much money does http://scholar.google.com/scholar_lookup?&title=EML4-ALK%20fusion%20gene%20and%20efficacy%20of%20an%20ALK%20kinase%20inhibitor%20in%20lung%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-0168&volume=14&pages=4275-4283&publication_year=2008&author=Koivunen%2CJP&author=Mermel%2CC&author=Zejnullahu%2CK&author=Murphy%2CC&author=Lifshits%2CE&author=Holmes%2CAJ&author=Choi%2CHG&author=Kim%2CJ&author=Chiang%2CD&author=Thomas%2CR&author=Lee%2CJ&author=Richards%2CWG&author=Sugarbaker%2CDJ&author=Ducko%2CC&author=Lindeman%2CN&author=Marcoux%2CJP&author=Engelman%2CJA&author=Gray%2CNS&author=Lee%2CC&author=Meyerson%2CM&author=J%C3%A4nne%2CPA generate?
- Get to know what's the income of https://doi.org/10.3181%2F00379727-204-43630
- http://scholar.google.com/scholar_lookup?&title=Regulation%20and%20function%20of%20insulin-like%20growth%20factor%20binding%20protein-1&journal=Proc%20Soc%20Exp%20Biol%20Med&doi=10.3181%2F00379727-204-43630&volume=204&pages=4-29&publication_year=1993&author=Lee%2CPD&author=Conover%2CCA&author=Powell%2CDR's revenue stream
- What are the total earnings of https://doi.org/10.1038%2Fsj.onc.1204660?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=IGF-2%20induces%20rapid%20beta-catenin%20relocation%20to%20the%20nucleus%20during%20epithelium%20to%20mesenchyme%20transition&journal=Oncogene&doi=10.1038%2Fsj.onc.1204660&volume=20&pages=4942-4950&publication_year=2001&author=Morali%2COG&author=Delmas%2CV&author=Moore%2CR&author=Jeanney%2CC&author=Thiery%2CJP&author=Larue%2CL?
- How much does https://doi.org/10.2337%2Fdiabetes.50.1.32 bring in each month?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Physiological%20differences%20in%20insulin-like%20growth%20factor%20binding%20protein-1%20%28IGFBP-1%29%20phosphorylation%20in%20IGFBP-1%20transgenic%20mice&journal=Diabetes&doi=10.2337%2Fdiabetes.50.1.32&volume=50&pages=32-38&publication_year=2001&author=Sakai%2CK&author=D%E2%80%99Ercole%2CAJ&author=Murphy%2CLJ&author=Clemmons%2CDR
- Financial intake of https://doi.org/10.1073%2Fpnas.210394297
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%201%20regulates%20the%20location%2C%20stability%2C%20and%20transcriptional%20activity%20of%20beta-catenin&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.210394297&volume=9&pages=12103-12108&publication_year=2000&author=Playford%2CMP&author=Bicknell%2CD&author=Bodmer%2CWF&author=Macaulay%2CVM?
- Get to know https://doi.org/10.1038%2Fnrc2536's earnings
- Get to know http://scholar.google.com/scholar_lookup?&title=Insulin%20and%20insulin-like%20growth%20factor%20signalling%20in%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2536&volume=8&pages=915-928&publication_year=2008&author=Pollak%2CM's earnings
- How much does https://doi.org/10.1093%2Fjnci%2Fdjp280 generate monthly?
- http://scholar.google.com/scholar_lookup?&title=Biomarkers%20predicting%20clinical%20outcome%20of%20epidermal%20growth%20factor%20receptor-targeted%20therapy%20in%20metastatic%20colorectal%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjp280&volume=101&pages=1308-1324&publication_year=2009&author=Siena%2CS&author=Sartore-Bianchi%2CA&author=Di%20Nicolantonio%2CF&author=Balfour%2CJ&author=Bardelli%2CA's financial summary
- How much revenue does https://doi.org/10.1200%2FJCO.2007.14.8197 bring in?
- http://scholar.google.com/scholar_lookup?&title=Guidelines%20for%20human%20epidermal%20growth%20factor%20receptor%202%20testing%3A%20biologic%20and%20methodologic%20considerations&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.14.8197&volume=27&pages=1323-1333&publication_year=2009&author=Sauter%2CG&author=Lee%2CJ&author=Bartlett%2CJM&author=Slamon%2CDJ&author=Press%2CMF's revenue stream
- How much revenue does https://doi.org/10.1200%2FJCO.2009.26.3996 produce monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Epidermal%20growth%20factor%20receptor%20biomarkers%20in%20non-small-cell%20lung%20cancer%3A%20a%20riddle%2C%20wrapped%20in%20a%20mystery%2C%20inside%20an%20enigma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.26.3996&volume=28&pages=903-905&publication_year=2010&author=Shepherd%2CFA&author=Tsao%2CMS
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12433720
- http://scholar.google.com/scholar_lookup?&title=Serum%20insulin%20like%20growth%20factor%20%28IGF%29%20and%20IGF%20binding%20protein%20levels%20and%20risk%20of%20lung%20cancer%3A%20a%20case%20control%20study%20nested%20in%20the%20beta%20carotene%20and%20retinol%20efficacy%20trial%20cohort&journal=Cancer%20Epidemiol%20Biomarkers%20Prev&volume=11&pages=1413-1418&publication_year=2002&author=Spitz%2CMR&author=Barnett%2CMJ&author=Goodman%2CGE&author=Thornquist%2CMD&author=Wu%2CX&author=Pollak%2CM income
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Receiver-operating%20characteristic%20%28ROC%29%20plots%3A%20a%20fundamental%20evaluation%20tool%20in%20clinical%20medicine&journal=Clin%20Chem&volume=39&pages=561-577&publication_year=1993&author=Zweig%2CMH&author=Campbell%2CG?
- How much does https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6605972?format=refman&flavour=references pull in?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Gualberto?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Gualberto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20L%20Hixon
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20L%20Hixon%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20D%20Karp
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20D%20Karp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20Li earns monthly
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Green
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Green%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20Dolled-Filhart make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20Dolled-Filhart%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L%20G%20Paz-Ares's gross income?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L%20G%20Paz-Ares%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Novello net monthly?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Novello%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20Blakely?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20Blakely%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20J%20Langer
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20J%20Langer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20N%20Pollak earning monthly?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20N%20Pollak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- https://s100.copyright.com/AppDispatchServlet?title=Pre-treatment%20levels%20of%20circulating%20free%20IGF-1%20identify%20NSCLC%20patients%20who%20derive%20clinical%20benefit%20from%20figitumumab&author=A%20Gualberto%20et%20al&contentID=10.1038%2Fsj.bjc.6605972©right=The%20Author%28s%29&publication=0007-0920&publicationDate=2010-11-23&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-SA's revenue stream
- How much does https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6605972?format=refman&flavour=citation make?
- Income figures for https://doi.org/10.1186/s13045-018-0616-2
- How much money does https://doi.org/10.1038/nrc3215 make?
- How much profit does https://doi.org/10.1007/s10911-012-9268-y make?
- How much profit is https://doi.org/10.1038/bjc.2011.412 making per month?
- What's the total monthly financial gain of https://doi.org/10.1038/bjc.2011.413?
- How profitable is https://www.protocols.io/?
- How much does https://www.natureindex.com/ rake in every month?
- How much money does http://www.naturechina.com make?
- How much revenue does https://www.natureasia.com/ja-jp bring in?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref